Is IUGNF or RYLD a better dividend investment in 2026?

IUGNF currently yields 1788.91% with a 5% 5-year dividend growth rate. RYLD yields 12.14% with 5% growth. The better choice depends on your goal: IUGNF offers higher current income.

What is the dividend yield difference between IUGNF and RYLD?

IUGNF has a forward dividend yield of 1788.91% ($2.00/share annually). RYLD yields 12.14% ($1.81/share annually). The yield gap is 1776.77 percentage points.

Home › Compare › IUGNF vs RYLD

IUGNF vs RYLD: Dividend Comparison 2026

IUGNF yields 1788.91% · RYLD yields 12.14%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 IUGNF wins by $3531675981.96M in total portfolio value

INVESTMENT

TIME HORIZON10 years

IUGNF

● Live price

1788.91%

Share price

$0.11

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$3531675982.01M

Annual income

$3,181,793,952,650,469.00

Full IUGNF calculator →

RYLD

● Live price

12.14%

Share price

$14.95

Annual div

$1.81

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$44.5K

Annual income

$2,587.35

Full RYLD calculator →

Portfolio growth — IUGNF vs RYLD

📍 IUGNF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	IUGNF	RYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, IUGNF + RYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

IUGNF pays

RYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IUGNF

Annual income on $10K today (after 15% tax)

$152,057.25/yr

After 10yr DRIP, annual income (after tax)

$2,704,524,859,752,898.50/yr

RYLD

Annual income on $10K today (after 15% tax)

$1,031.60/yr

After 10yr DRIP, annual income (after tax)

$2,199.25/yr

At 15% tax rate, IUGNF beats the other by $2,704,524,859,750,699.50/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IUGNF + RYLD for your $10,000?

IUGNF: 50%RYLD: 50%

100% RYLD50/50100% IUGNF

Portfolio after 10yr

$1765837991.02M

Annual income

$1,590,896,976,326,528.20/yr

Blended yield

90.09%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IUGNF buys

RYLD buys

No recent congressional trades found for IUGNF or RYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricIUGNFRYLD

Forward yield	1788.91% ✓	12.14%
Annual dividend / share	$2.00 ✓	$1.81
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$3531675982.01M ✓	$44.5K
Annual income after 10y	$3,181,793,952,650,469.00 ✓	$2,587.35
Total dividends collected	$3506616114.25M ✓	$18.8K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: IUGNF vs RYLD ($10,000, DRIP)

Year	IUGNF Portfolio	IUGNF Income/yr	RYLD Portfolio	RYLD Income/yr	Gap
1← crossover	$189,591	$178,890.88	$11,914	$1,213.65	+$177.7K → IUGNF
2	$3,372,589	$3,169,726.93	$14,099	$1,351.30	+$3.36M → IUGNF
3	$56,305,450	$52,696,779.78	$16,580	$1,494.55	+$56.29M → IUGNF
4	$882,465,426	$822,218,594.62	$19,384	$1,642.61	+$882.45M → IUGNF
5	$12,987,684,313	$12,043,446,306.47	$22,535	$1,794.70	+$12987.66M → IUGNF
6	$179,550,479,073	$165,653,656,858.63	$26,063	$1,950.00	+$179550.45M → IUGNF
7	$2,332,406,409,977	$2,140,287,397,368.80	$29,995	$2,107.69	+$2332406.38M → IUGNF
8	$28,479,672,886,997	$25,983,998,028,321.59	$34,361	$2,266.99	+$28479672.85M → IUGNF
9	$326,992,550,798,860	$296,519,300,809,773.56	$39,194	$2,427.12	+$326992550.76M → IUGNF
10	$3,531,675,982,005,250	$3,181,793,952,650,469.00	$44,525	$2,587.35	+$3531675981.96M → IUGNF

IUGNF vs RYLD: Complete Analysis 2026

IUGNF — Stock

Imugene Limited, a clinical stage immuno-oncology company, develops a range of immunotherapies to activate the immune system of cancer patients to treat and eradicate tumors in Australia. Its lead product is HER-Vaxx, a HER2-positive cancer vaccine that stimulates a polyclonal antibody response against HER2/neu receptors in gastric and breast cancer. The company's HER-Vaxx is in Phase 1b/2 study for gastric cancer. It also engages in developing PD1-Vaxx, a cancer vaccine that aims to induce the body to produce polyclonal antibodies that block PD-1 signalling; and CF33, a combination of genomic sequences from various vaccinia virus strains to generate potent virus. The company has a research collaboration with Celularity Inc. to develop the combination of Imugene's CD19 oncolytic virus technology and Celularity's CD19 targeting allogeneic chimeric antigen receptor T-cell therapy, CyCART-19 for the treatment of solid tumors; and has a strategic collaboration with Eureka Therapeutics, Inc. Imugene Limited was incorporated in 1986 and is based in Sydney, Australia.

Full IUGNF Calculator →

RYLD — ETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →

📬

Get this IUGNF vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IUGNF vs SCHD IUGNF vs JEPI IUGNF vs O IUGNF vs KO IUGNF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.